Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Sep;14(3):233-239.
doi: 10.26574/maedica.2019.14.3.233.

Environmental Factors in Romanian and Belgian Patients with Inflammatory Bowel Disease - a Retrospective Comparative Study

Carmen Monica Preda  1 , Teodora Manuc  1 , Doina Istratescu  1 , Edouard Louis  2 , Cristian Baicus  3 , Irina Sandra  1 , Mircea Diculescu  1 , Catherine Reenaers  2 , Catherine van Kemseke  2 , Maria Nitescu  4 , Cristian Tieranu  5 , Corina Georgiana Sandu  1 , Gabriela Oprea-Calin  6 , Letitia Tugui  1 , Siyana Viziru  1 , Cosmin-Alexandru Ciora  1 , Liliana-Simona Gheorghe  1 , Mircea Manuc  1
Affiliations
Editorial

Environmental Factors in Romanian and Belgian Patients with Inflammatory Bowel Disease - a Retrospective Comparative Study

Carmen Monica Preda et al. Maedica (Bucur). 2019 Sep.

Abstract

Background:Several environmental factors have been associated with onset of inflammatory bowel diseases (IBD): smoking, hygiene, microorganisms, oral contraceptive pills (OCPs), non-steroid anti-inflammatory drugs, antibiotics, appendectomy, diet, breastfeeding, vitamin D, stress and ambient air pollution. The aim of this study was to investigate the prevalence of these factors in a Romanian and Belgian population with IBD. Material and methods:A total of 129 patients with an IBD diagnosis (76 from Romania and 53 from Belgium) participated in an interview and were asked to fill in a questionnaire regarding environmental factors before and after the onset of IBD; 35 Romanian and 21 Belgian healthy individuals constituted the control group. Results:A total of 40 patients with ulcerative colitis (UC) and 89 with Crohn's disease (CD) were included. Gender distribution was 43% males and 57% females. They had a median age of 42 years (range between 19-74 years), a median disease duration of eight years and 79% were in clinical remission. Both Romanian and Belgian IBD patients reported an increased antibiotic consumption before IBD onset compared to controls: 58% vs 10% (p<0.001) and 51% vs 5% (p<0.001), respectively. Belgian IBD patients declared significantly more frequent OCP use (53% vs 9%, p <0.001), they were breastfed in a lower proportion (49% vs 76%, p <0.001) and had experienced a higher level of psychosocial stress (p<0.001). Conclusion:Antibiotic consumption before IBD onset may play a pivotal role in IBD development in both Romanian and Belgian populations. In Belgian patients, OCP consumption, a higher level of psychosocial stress and lack of breastfeeding may also be involved.

PubMed Disclaimer

Figures

TABLE 1.
TABLE 1.
A comparison between Romanian and Belgian IBD patients
TABLE 2.
TABLE 2.
A comparison between Romanian and Belgian CD patients
TABLE 3.
TABLE 3.
A comparison between Romanian and Belgian UC patients
FIGURE 1.
FIGURE 1.
Prevalence of different environmental factors in Belgian patients with IBD, prior to disease onset (according to questionnaires)
FIGURE 2.
FIGURE 2.
Prevalence of different environmental factors in Romanian patients with IBD, prior to disease onset (according to questionnaires)
See this image and copyright information in PMC

References

    1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54. - PubMed
    1. Gheorghe C, Pascu O, Gheorghe L, et al. Epidemiology of inflammatory bowel disease in adults who refer to gastroentero­logy care in Romania: a multicentric study. Eur J Gastroenterol Hepatol. 2004;16:1153–1161. - PubMed
    1. Preda C, Fulger LE, Gheorghe L, et al. Infliximab andAdalimumab in Crohn’sdisease: real- life data from a nationalcohortstudy. Curr Health Sci J. 2016;2:115–124. - PMC - PubMed
    1. Gologan S, Iacob R, Preda CM, et al. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn’s disease. J Gastrointestin Liver Dis. 2012;1:39–44. - PubMed
    1. Klement E, Cohen RV, Boxman J, et al. Breastfeeding and risk of inflammatory bowel disease: A systematic review with meta-analysis. Am J Clin Nutr. 2004;80:1342–1352. - PubMed

Publication types

LinkOut - more resources